Have You Ever Been Denied a Diagnosis And Told That Your Pain is Psychosomatic? Part Two

Note: This is part two of a two part story. Don't forget to go back and read part one! Meghan O’Rouke, the author of the NYT best-selling book Invisible Kingdom,…

Continue Reading Have You Ever Been Denied a Diagnosis And Told That Your Pain is Psychosomatic? Part Two

The Nanopore Sequencing Test Reduces Diagnosis From Decades to Days for Multiple Rare Disorders

Researchers from Australia’s Garvan Institute have joined with collaborators in Israel and the UK in identifying neuromuscular and neurological genetic diseases that have been difficult to diagnose due to the…

Continue Reading The Nanopore Sequencing Test Reduces Diagnosis From Decades to Days for Multiple Rare Disorders
Looking at the Histopathology Associated with Monoclonal Gammopathy of Renal Significance
https://pixabay.com/en/concept-man-papers-person-plan-1868728/

Looking at the Histopathology Associated with Monoclonal Gammopathy of Renal Significance

According to a recent article, a new study looked into the histopathologic spectrum of patients with monoclonal gammopathy of renal significance (MGRS). Monoclonal Gammopathy of Undetermined Significance (MGUS) Monoclonal gammopathy…

Continue Reading Looking at the Histopathology Associated with Monoclonal Gammopathy of Renal Significance
Trialbee and ERGOMED Have Partnered to Recruit Patients for New Rare Disease Innovation Center
rawpixel / Pixabay

Trialbee and ERGOMED Have Partnered to Recruit Patients for New Rare Disease Innovation Center

According to a recent article, Trialbee and ERGOMED have partnered to become the platform for patient recruitment for their new Rare Disease Innovation Center. Trialbee Trialbee is the leading platform…

Continue Reading Trialbee and ERGOMED Have Partnered to Recruit Patients for New Rare Disease Innovation Center

CRISPR Continues to Cut Impressive Numbers in Beta-Thalassemia, Sickle Cell Disease, and More

A year ago, Paddy Doherty’s doctor told him that he had a rare hereditary disease called transthyretin (ATTR) amyloidosis, the same disease that had killed his father. As reported in…

Continue Reading CRISPR Continues to Cut Impressive Numbers in Beta-Thalassemia, Sickle Cell Disease, and More